Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Factors Associated With Blood Pressure Control Failure to Intravenous Labetalol in Severe Preeclampsia

View source ↗

Summary

This clinical trial investigates factors associated with failure to achieve blood pressure control using intravenous labetalol in patients with severe preeclamp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Severe Preeclampsia | Status: NOT_YET_RECRUITING